Epsilon Healthcare Limited

FRC's fair value estimate for Epsilon Healthcare Limited, and the rating behind it. HDRPF last traded at $0.0014; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Epsilon Healthcare Limited. Starting points for Epsilon Healthcare Limited: beta 0.71 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Epsilon Healthcare Limited. Epsilon Healthcare Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Epsilon Healthcare Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Epsilon Healthcare Limited. Epsilon Healthcare Limited has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Epsilon Healthcare Limited valued side by side against its closest peers. Epsilon Healthcare Limited is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Epsilon Healthcare Limited, and how their positions are changing. At a $544,746 market value, institutional positions materially move Epsilon Healthcare Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Epsilon Healthcare Limited executives and directors. Shares of Epsilon Healthcare Limited have traded between $0.0014 and $0.0014 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Epsilon Healthcare Limited. Epsilon Healthcare Limited is a $544,746 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Epsilon Healthcare Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Epsilon Healthcare Limited. Coverage tracks Epsilon Healthcare Limited within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.